Composition and method to alleviate joint pain using phospholipids and astaxanthin 机翻标题: 暂无翻译,请尝试点击翻译按钮。

公开号/公开日
US2015182552 A1 2015-07-02 [US20150182552]US9913810 B2 2018-03-13 [US9913810] / 2015-07-022018-03-13
申请号/申请日
2015US-14645890 / 2015-03-12
发明人
MINATELLI JOHN A;HILL W STEPHEN;MOERCK RUDI E;
申请人
US NUTRACEUTICALS D VALENSA INTERNATIONAL;
主分类号
IPC分类号
A01N-031/04A23L-033/10A23L-033/115A23L-033/12A61K-009/00A61K-009/48A61K-031/122A61K-031/202A61K-031/661A61K-031/6615A61K-031/685A61K-031/7028A61K-031/728A61K-035/60A61K-036/02A61K-036/05A61K-036/185A61K-036/324A61K-036/535A61K-036/74A6
摘要
(US9913810) A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain.  The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan).  The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid.  It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2009US-61227872 2009-07-23 2010US-12840372 2010-07-21 2010US-61345652 2010-05-18 2013US-13914725 2013-06-11 2014US-14217515 2014-03-18 2015US-14645890 2015-03-12
主权利要求
(US9913810) That which is claimed is: 1.  A dietary supplement composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain, the composition comprising astaxanthin derived from Haematococcus pluvialis, pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments free from amino acid conjugation and having a molecular weight of 0.5 to 300 kilodaltons (kDa), and a krill or algae oil or phospholipid, wherein the astaxanthin is 0.1 to 15 percent by weight of the krill or algae oil or phospholipid, wherein the composition includes 50 to 500 mg of the krill or algae oil or phospholipid; 0.5 to 12 mg of the astaxanthin derived from Haematococcus pluvialis; and 10 to 70 mg of the pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kDa, and wherein the composition is formulated in an oral dosage form and in a single dosage capsule. 2. The dietary supplement composition according to claim 1, further comprising a pharmaceutical or food grade diluent. 3. The dietary supplement composition according to claim 1, wherein the phospholipid is selected from the group consisting of Phosphatidylcholine, Phosphatidylethanolamine, Phosphatidylserine, Phosphatidylinositol, Phosphatidic acid, Lyso-Phosphatidylcholine, Lyso-Phosphatidylethanolamine, and Lyso-Phosphatidylserine. 4. The dietary supplement composition according to claim 1, wherein the phospholipid comprises at least one of a plant, algae, animal source and synthetic derivative.
法律状态
(US9913810) LEGAL DETAILS FOR US2015182552  Actual or expected expiration date=2035-03-12    Legal state=ALIVE    Status=GRANTED     Event publication date=2015-03-12  Event code=US/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=US US14645890  Application date=2015-03-12  Standardized application number=2015US-14645890     Event publication date=2015-03-12  Event code=US/EXMR  Event type=Administrative notifications  USPTO Examiner Name Primary Examiner: BOWERS, ERIN M    Event publication date=2015-03-12  Event code=US/ART  Event type=Administrative notifications  USPTO Art Group  ART=1653     Event publication date=2015-03-12  Event code=US/ENT  Event type=Administrative notifications  Entity Status Set to Undiscounted Business Entity Status: UNDISCOUNTED    Event publication date=2015-03-12  Event code=US/AIA  Event type=Administrative notifications  First Inventor File Indicated:  AIA=Yes     Event publication date=2015-03-12  Event code=US/DK  Event type=Examination events  Attorney Docket Number Docket Nbr: 65452CON1-CIP1    Event publication date=2015-03-12  Event code=US/CUST  Event type=Examination events  Attorney/Agent Customer Number Customer Nbr: 27975    Event publication date=2015-03-12  Event code=US/PTARDY  Event indicator=Pos  Event type=Examination events  Patent Term Adjustment - Ready for Examination    Event publication date=2015-03-12  Event code=US/ENT  Event type=Administrative notifications  Entity Status Set to Undiscounted    Event publication date=2015-03-19  Event code=US/DISCSEF  Event type=OAI  Electronic Information Disclosure Statement    Event publication date=2015-03-19  Event code=US/IDS  Event type=Examination events  Event type=OAI  Information Disclosure Statement Filed    Event publication date=2015-03-20  Event code=US/DISCSEF  Event type=OAI  Electronic Information Disclosure Statement    Event publication date=2015-03-25  Event code=US/APPFILEREC  Event type=Administrative notifications  Event type=OAO  Filing Receipt    Event publication date=2015-04-21  Event code=US/AS  Event type=Change of name or address  Event type=Reassignment  Assignment Owner: U.S. NUTRACEUTICALS, LLC, D/B/A VALENSA INTERNATIO  Effective date of the event=2015-04-07  ASSIGNMENT OF ASSIGNORS INTEREST ASSIGNORS:MINATELLI, JOHN A. HILL, W. STEPHEN MOERCK, RUDI E. REEL/FRAME:035454/0045     Event publication date=2015-06-04  Event code=US/DISCSEF  Event type=OAI  Electronic Information Disclosure Statement    Event publication date=2015-06-04  Event code=US/IDS  Event type=Examination events  Event type=OAI  Information Disclosure Statement Filed    Event publication date=2015-07-02  Event code=US/A1  Event type=Examination events  Application published  Publication country=US  Publication number=US2015182552  Publication stage Code=A1  Publication date=2015-07-02  Standardized publication number=US20150182552     Event publication date=2015-07-02  Event code=US/PGPUBN  Event indicator=Pos  Event type=Examination events  Event type=OAO  PG-Pub Issue Notification    Event publication date=2015-07-23  Event code=US/DISCSEF  Event type=OAI  Electronic Information Disclosure Statement    Event publication date=2015-10-05  Event code=US/DISCSEF  Event type=OAI  Electronic Information Disclosure Statement    Event publication date=2015-10-05  Event code=US/IDS  Event type=Examination events  Event type=OAI  Information Disclosure Statement Filed    Event publication date=2015-10-14  Event code=US/DOCK  Event indicator=Pos  Event type=Examination events  Case Docketed to Examiner    Event publication date=2015-11-24  Event code=US/RESTREQ  Event type=Examination events  Event type=Corrections  Event type=OAO  Restriction/Election Requirement    Event publication date=2016-01-19  Event code=US/APE  Event type=Corrections  Preliminary amendments    Event publication date=2016-01-19  Event code=US/ELC  Event type=Examination events  Event type=OAI  Response to Election / Restriction Filed    Event publication date=2016-02-11  Event code=US/IDS  Event type=Examination events  Event type=OAI  Information Disclosure Statement Filed    Event publication date=2016-03-17  Event code=US/CTNF  Event type=Examination events  Event type=OA  Event type=OAO  Non-Final Rejection    Event publication date=2016-06-24  Event code=US/INVSUM  Event type=Examination events  Event type=OAI  Event type=INT  Interview Summary- Applicant Initiated    Event publication date=2016-08-09  Event code=US/136G  Event type=OAO  Request for Extension of Time - Granted    Event publication date=2016-08-09  Event code=US/CTNFR  Event type=Examination events  Event type=OAI  Response after Non-Final Action    Event publication date=2016-08-09  Event code=US/IDS  Event type=Examination events  Event type=OAI  Information Disclosure Statement Filed    Event publication date=2016-08-09  Event code=US/DC  Event indicator=Neg  Event type=Examination events  Terminal Disclaimer Filed    Event publication date=2016-11-01  Event code=US/CTFR  Event type=Examination events  Event type=OA  Event type=OAO  Final Rejection    Event publication date=2017-01-11  Event code=US/INVSUM  Event type=Examination events  Event type=OAI  Event type=INT  Interview Summary- Applicant Initiated    Event publication date=2017-05-17  Event code=US/DISCSEF  Event type=OAI  Electronic Information Disclosure Statement    Event publication date=2017-05-17  Event code=US/RCEX  Event type=Examination events  Event type=RCE  Event type=OAI  Request for Continued Examination (RCE)    Event publication date=2017-05-17  Event code=US/136G  Event type=OAO  Request for Extension of Time - Granted    Event publication date=2017-05-17  Event code=US/IDS  Event type=Examination events  Event type=OAI  Information Disclosure Statement Filed    Event publication date=2017-05-18  Event code=US/DRCECAP  Event type=RCE  Event type=OAO  Disposal for a RCE / CPA / R129    Event publication date=2017-06-01  Event code=US/DISCSEF  Event type=OAI  Electronic Information Disclosure Statement    Event publication date=2018-01-11  Event code=US/EXAC  Event type=Examination events  Event type=OAO  Examiner's Amendment Communication    Event publication date=2018-01-19  Event code=US/NOAM  Event indicator=Pos  Event type=Examination events  Event type=OAO  Mail Notice of Allowance    Event publication date=2018-01-30  Event code=US/APRDY  Event indicator=Pos  Event type=Examination events  Application Is Considered Ready for Issue    Event publication date=2018-02-21  Event code=US/PAT  Event indicator=Pos  Event type=Event indicating In Force  Patented Case    Event publication date=2018-02-21  Event code=US/ISSM  Event indicator=Pos  Event type=Examination events  Event type=OAO  Event type=Restitution or restoration  Issue Notification Mailed    Event publication date=2018-03-13  Event code=US/B2  Event indicator=Pos  Event type=Event indicating In Force  Granted patent as second publication  Publication country=US  Publication number=US9913810  Publication stage Code=B2  Publication date=2018-03-13  Standardized publication number=US9913810
专利类型码
A1B2
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部